Nkarta NKTX
NASDAQ NKTX
$2.66 +0.19 (+7.69%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nkarta (NKTX) Free Cash Flow (2019 - 2026)

Nkarta (NKTX) posted quarterly Free Cash Flow of -$28.6 million for Q1 2026, up 5.04% year-over-year from -$27.2 million in Q1 2025, and down 28.84% quarter-over-quarter from -$22.2 million in Q4 2025.

Nkarta (NKTX) Free Cash Flow (2019 - 2026) Analysis & Trends

Nkarta's Free Cash Flow history runs 8 years deep, the most recent figure standing at -$28.6 million for Q1 2026.

  • In Q1 2026, Free Cash Flow rose 5.04% year-over-year to -$28.6 million; the TTM figure through Mar 2026 stood at -$88.4 million (up 16.26% YoY), while the FY2025 annual figure was -$89.9 million, up 13.64% from the prior year.
  • Free Cash Flow for Q1 2026 stood at -$28.6 million, down from -$22.2 million in the prior quarter.
  • The five-year high for Free Cash Flow was -$18.7 million in Q3 2025, with the low at -$42.4 million in Q4 2022.
  • The 5-year median for Free Cash Flow is -$25.6 million (2023), against an average of -$25.9 million.
  • The sharpest annual moves came in 2022 and 2023: Free Cash Flow tumbled 127.0% in 2022, then increased 28.81% in 2023.
  • Nkarta's Free Cash Flow stood at -$42.4 million in 2022, then climbed by 28.81% to -$30.2 million in 2023, then increased by 14.28% to -$25.9 million in 2024, then increased by 14.11% to -$22.2 million in 2025, then declined by 28.84% to -$28.6 million in 2026.
  • Business Quant data shows NKTX's Free Cash Flow at -$28.6 million in Q1 2026, -$22.2 million in Q4 2025, and -$18.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -563.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 437.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 292.04 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 433.84 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -95.09 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 477.44 Mn
10 Nkarta 201.14 Mn 201.14 Mn - -24.41 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -24.41 Mn
Jun 30, 2026 -24.41 Mn
Mar 31, 2026 -28.61 Mn
Mar 31, 2026 -28.61 Mn
Dec 31, 2025 -22.21 Mn
Dec 31, 2025 -22.21 Mn
Sep 30, 2025 -18.68 Mn
Sep 30, 2025 -18.68 Mn
Jun 30, 2025 -18.89 Mn
Jun 30, 2025 -18.89 Mn
Mar 31, 2025 -30.13 Mn
Mar 31, 2025 -30.13 Mn
Dec 31, 2024 -25.85 Mn
Dec 31, 2024 -25.85 Mn
Sep 30, 2024 -25.32 Mn
Sep 30, 2024 -25.32 Mn
Jun 30, 2024 -24.25 Mn
Jun 30, 2024 -24.25 Mn
Mar 31, 2024 -28.68 Mn
Mar 31, 2024 -28.68 Mn